Drug Profile
Elbasvir/grazoprevir/uprifosbuvir
Alternative Names: Elbasvir/grazoprevir/MK-3682; MK 3682/MK 8742/MK 5172; MK-3682ALatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antivirals; Macrocyclic compounds; Small molecules; Uracil nucleotides
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 06 May 2016 Discontinued - Phase-II for Hepatitis C (PO) (Merck pipeline, May 2016)